logo
Share SHARE
FONT-SIZE Plus   Neg

CVC, ValueAct Confirm Intention Not To Make Offer For Misys - Quick Facts

CVC Capital Partners Ltd. and ValueAct Capital Master Fund, L.P. confirmed that they do not intend to proceed with an offer for Misys Plc (MSY.L, MUSJF.PK).

On March 5, 2012, funds advised by CVC and ValueAct had announced that they had concluded an agreement to work together with a view to making a recommended joint cash offer for Misys.

On March 19, Magic Bidco Ltd., an investment vehicle indirectly owned by funds managed or advised by Vista Equity Partners, LLC had announced a firm intention to make an offer for Misys pursuant to Rule 2.7 of the City Code on Takeovers and Mergers.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The biotech space is not for the faint hearted, given the ebbs and flows in terms of the returns from investing in it. However, for one who perseveres and astutely devises strategies with full cognizance of key regulatory events coming up, the probability of drug candidates getting FDA's blessings and sympathy plays in the space, it provide a sea of opportunity and huge upside prospects. Alcobra Ltd.'s Investigational New Drug Applications for drug candidate MDX in Attention Deficit Hyperactivity Disorder and Fragile X Syndrome have been put on full clinical hold, following adverse neurological findings in a pre-clinical study. Chinese conglomerate Dalian Wanda is in talks to buy Dick Clark Productions, as the company aims to expand in to the US entertainment industry. According to reports, Dalian Wanda Group has started preliminary talks to buy Dick Clark Productions for a price of about $1 billion. Dick Clark Productions...
comments powered by Disqus
Follow RTT